SEQUENT SCIENTIFIC
Back to Cashflow Statement
|
SEQUENT SCIENTIFIC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.44 Cr | ₹32 Cr | ₹67 Cr | ₹-139 Cr | ₹-43 Cr |
What is the latest Cash Flow from Financing Activities ratio of SEQUENT SCIENTIFIC ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1.44 Cr |
Mar2023 | ₹32 Cr |
Mar2022 | ₹67 Cr |
Mar2021 | ₹-139 Cr |
Mar2020 | ₹-43 Cr |
How is Cash Flow from Financing Activities of SEQUENT SCIENTIFIC Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1.44 Cr | Negative | |
Mar2023 | ₹32 Cr | -52.08 | |
Mar2022 | ₹67 Cr | Positive | |
Mar2021 | ₹-139 Cr | Negative | |
Mar2020 | ₹-43 Cr | - |
Compare Cash Flow from Financing Activities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹4,741.9 Cr | -4% | 5.7% | 57.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,254.0 Cr | -2.5% | -4.9% | 8.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,374.0 Cr | -2.7% | -0.9% | 42.5% | Stock Analytics | |
CIPLA | ₹119,795.0 Cr | -1.5% | 0.1% | -4.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,698.0 Cr | -2.6% | 8.3% | 7.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,218.0 Cr | -2.6% | -3.7% | 11.9% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | -4% |
5.7% |
57.8% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses